Our therapeutic areas of focus are vitamin D deficiency and osteoporosis
When it comes to bone health the choice is simple. Accrete-D3 is the least expensive calcium and vitamin D3 brand that offers a choice of presentations for patients and prescribers. '11 Drug Tariff May 2019
Accrete-D3 Film-coated tablets
Accrete-D3 One a Day 1000 mg / 880 IU Chewable Tablets
Binosto® Alendronic acid
Binosto (alendronate 70mg) is an effervescent buffered solution with high acid neutralising capacity1. 1 SMPC
Binosto 70 mg effervescent tablets
Fultium-D3 is the UK’s leading branded range of licensed vitamin-D3 dosing options1. Fultium-D3 provides a range of capsules and drops for the treatment and prevention of vitamin-D3 deficiency for use across all ages. 1 IMS Data June 2019
Fultium-D3 800IU capsules
Fultium-D3 3,200IU capsules
Fultium-D3 20,000IU capsules
Movymia® ▼ Teriparatide
Movymia▼ (teriparatide 20 μg/80 μL) is the first biosimilar launched by Thornton & Ross, building on our expertise in bone health. Teriparatide is recommended as an alternative treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women1.
NICE. Technology Appraisal Guidance TA161. 2018. Available at: https://www.nice.org.uk/Guidance/TA161
Movymia 20 micrograms/80 microliters solution for injection
For SmPC and PILs follow the links which will take you to the electronic Medicines Compendium (emc) website which is a non-Thornton & Ross website. https://www.medicines.org.uk/emc/.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Thornton & Ross Ltd.
Last updated: January 2020 TR-001